Despite the improved clinical sensitivity of the Roche benzodiazepines II assay it cannot replace mass spectrometry in all patient populations by Nicole V. Tolan, Sacha Uljon, M. Lauren Donnelly-Morell, Melissa Zhao, Grace K. Mahowald, Marion L. Snyder, Lindsey Contella, Elizabeth D. Urwiller, Maria Daluz Fernandes, Phillip Kang, Stacy E.F. Melanson

Get full text